ACE2 and COVID-19: Interestingly, the interaction between ACE2 and UBR4 is blocked by the kinase GLK (MAP4K3) [28]; GLK is overexpressed in airway epithelial cells from human COVID-19 patients and in SARS-CoV-2 spike (S) protein-stimulated human HCC827 lung epithelial cells [28].